287 related articles for article (PubMed ID: 15793287)
1. BRAF mutations in aberrant crypt foci and hyperplastic polyposis.
Beach R; Chan AO; Wu TT; White JA; Morris JS; Lunagomez S; Broaddus RR; Issa JP; Hamilton SR; Rashid A
Am J Pathol; 2005 Apr; 166(4):1069-75. PubMed ID: 15793287
[TBL] [Abstract][Full Text] [Related]
2. Concordant CpG island methylation in hyperplastic polyposis.
Chan AO; Issa JP; Morris JS; Hamilton SR; Rashid A
Am J Pathol; 2002 Feb; 160(2):529-36. PubMed ID: 11839573
[TBL] [Abstract][Full Text] [Related]
3. Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea.
Kim KM; Lee EJ; Ha S; Kang SY; Jang KT; Park CK; Kim JY; Kim YH; Chang DK; Odze RD
Am J Surg Pathol; 2011 Sep; 35(9):1274-86. PubMed ID: 21836485
[TBL] [Abstract][Full Text] [Related]
4. Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans.
Rosenberg DW; Yang S; Pleau DC; Greenspan EJ; Stevens RG; Rajan TV; Heinen CD; Levine J; Zhou Y; O'Brien MJ
Cancer Res; 2007 Apr; 67(8):3551-4. PubMed ID: 17440063
[TBL] [Abstract][Full Text] [Related]
5. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.
Yuen ST; Davies H; Chan TL; Ho JW; Bignell GR; Cox C; Stephens P; Edkins S; Tsui WW; Chan AS; Futreal PA; Stratton MR; Wooster R; Leung SY
Cancer Res; 2002 Nov; 62(22):6451-5. PubMed ID: 12438234
[TBL] [Abstract][Full Text] [Related]
6. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.
Kambara T; Simms LA; Whitehall VL; Spring KJ; Wynter CV; Walsh MD; Barker MA; Arnold S; McGivern A; Matsubara N; Tanaka N; Higuchi T; Young J; Jass JR; Leggett BA
Gut; 2004 Aug; 53(8):1137-44. PubMed ID: 15247181
[TBL] [Abstract][Full Text] [Related]
7. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas.
Chan TL; Zhao W; Leung SY; Yuen ST;
Cancer Res; 2003 Aug; 63(16):4878-81. PubMed ID: 12941809
[TBL] [Abstract][Full Text] [Related]
8. Molecular classification and genetic pathways in hyperplastic polyposis syndrome.
Carvajal-Carmona LG; Howarth KM; Lockett M; Polanco-Echeverry GM; Volikos E; Gorman M; Barclay E; Martin L; Jones AM; Saunders B; Guenther T; Donaldson A; Paterson J; Frayling I; Novelli MR; Phillips R; Thomas HJ; Silver A; Atkin W; Tomlinson IP
J Pathol; 2007 Aug; 212(4):378-85. PubMed ID: 17503413
[TBL] [Abstract][Full Text] [Related]
9. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma.
Carr NJ; Mahajan H; Tan KL; Hawkins NJ; Ward RL
J Clin Pathol; 2009 Jun; 62(6):516-8. PubMed ID: 19126563
[TBL] [Abstract][Full Text] [Related]
10. Genetic and epigenetic changes in aberrant crypt foci and serrated polyps.
Suehiro Y; Hinoda Y
Cancer Sci; 2008 Jun; 99(6):1071-6. PubMed ID: 18384435
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and molecular characteristics of hyperplastic polyposis.
Rashid A; Houlihan PS; Booker S; Petersen GM; Giardiello FM; Hamilton SR
Gastroenterology; 2000 Aug; 119(2):323-32. PubMed ID: 10930367
[TBL] [Abstract][Full Text] [Related]
12. Deletion mutation of BRAF in a serrated adenoma from a patient with familial adenomatous polyposis.
Lee EJ; Park CK; Kim JW; Chang DK; Kim KM
APMIS; 2007 Aug; 115(8):982-6. PubMed ID: 17696956
[TBL] [Abstract][Full Text] [Related]
13. KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy.
Yamane LS; Scapulatempo-Neto C; Alvarenga L; Oliveira CZ; Berardinelli GN; Almodova E; Cunha TR; Fava G; Colaiacovo W; Melani A; Fregnani JH; Reis RM; Guimarães DP
Oncol Rep; 2014 Oct; 32(4):1419-26. PubMed ID: 25050586
[TBL] [Abstract][Full Text] [Related]
14. Somatic BRAF-V600E mutations in familial colorectal cancer.
Vandrovcova J; Lagerstedt-Robinsson K; Påhlman L; Lindblom A
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2270-3. PubMed ID: 17119056
[TBL] [Abstract][Full Text] [Related]
15. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer.
Jass JR; Baker K; Zlobec I; Higuchi T; Barker M; Buchanan D; Young J
Histopathology; 2006 Aug; 49(2):121-31. PubMed ID: 16879389
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy.
Spring KJ; Zhao ZZ; Karamatic R; Walsh MD; Whitehall VL; Pike T; Simms LA; Young J; James M; Montgomery GW; Appleyard M; Hewett D; Togashi K; Jass JR; Leggett BA
Gastroenterology; 2006 Nov; 131(5):1400-7. PubMed ID: 17101316
[TBL] [Abstract][Full Text] [Related]
17. The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature.
Young J; Jass JR
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1778-84. PubMed ID: 17035382
[TBL] [Abstract][Full Text] [Related]
18. Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis.
Boparai KS; Dekker E; Van Eeden S; Polak MM; Bartelsman JF; Mathus-Vliegen EM; Keller JJ; van Noesel CJ
Gastroenterology; 2008 Dec; 135(6):2014-8. PubMed ID: 19013464
[TBL] [Abstract][Full Text] [Related]
19. Frequent CpG island methylation in serrated adenomas of the colorectum.
Park SJ; Rashid A; Lee JH; Kim SG; Hamilton SR; Wu TT
Am J Pathol; 2003 Mar; 162(3):815-22. PubMed ID: 12598316
[TBL] [Abstract][Full Text] [Related]
20. Intermediate serrated polyp as an intermediate lesion of hyperplastic polyp and sessile serrated polyp/adenoma in terms of morphological and molecular features.
Kwon HJ; Cho NY; Chang MS; Kim YS; Kang GH
Hum Pathol; 2014 Aug; 45(8):1759-65. PubMed ID: 24935059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]